Utang agregat perusahaan: ESSA Pharma, Inc. (EPIX)

ESSA Pharma Inc. (EPIX) maintains a debt profile that allows it to filter out market noise, where the 0.00 mark serves as a relevant indicator. Borrowing dynamics correlate with molecule selectivity and grant support within the oncology ecosystem. Operational flexibility is ensured through the outsourcing of production to US-based CMO facilities. In the long term, a unique approach to prostate receptors will create the conditions for pricing power in therapy.

Gunggung utang perusahaan: ESSA Pharma Inc. (EPIX) kanggo 04.07.2022 - 25.10.2025

Rincian analitis lan laporan data perusahaan ESSA Pharma Inc. (EPIX)

- rega lan prakiraan konsensus rega:

Rega saham essapharma.com|EPIX - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar ESSA Pharma Inc|EPIX - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham ESSA Pharma|EPIX - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku essapharma.com|EPIX - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi ESSA Pharma Inc.|EPIX - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal essapharma.com|EPIX - Gunggung utang perusahaan|Utang marang nilai buku ESSA Pharma Inc

Ringkesan analitik perusahaan:ESSA Pharma, Inc. EPIX

Managing debt load is critical for assessing the financial stability of the biotechnology sector while minimizing default risks. For ESSA Pharma Inc. (EPIX), with its focused team of oncology experts, this parameter reflects the funding efficiency of clinical trials. The total volume of all liabilities, through the debt trend, allows for an assessment of the balance between borrowed capital and the investment potential for business development.

Analisis pesaing ESSA Pharma Inc.